Modeling islet enhancers using deep learning identifies candidate causal variants at loci associated with T2D and glycemic traits
Authors:
- D. Leland TaylorD. Leland Taylor
- Henry J. TaylorHenry J. Taylor
- DIAMANTE ConsortiumDCDIAMANTE Consortium
- Shuibing ChenShuibing Chen
Open Access
- 21 August 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (35)
Abstract
Genetic association studies have identified hundreds of independent signals associated with type 2 diabetes (T2D) and related traits. Despite these successes, the identification of specific causal variants underlying a genetic association signal remains challenging. In this study, we describe a deep learning (DL) method to analyze the impact of sequence variants on enhancers. Focusing on pancreatic islets, a T2D relevant tissue, we show that our model learns islet-specific transcription factor (TF) regulatory patterns and can be used to prioritize candidate causal variants. At 101 genetic signals associated with T2D and related glycemic traits where multiple variants occur in linkage disequilibrium, our method nominates a single causal variant for each association signal, including three variants previously shown to alter reporter activity in islet-relevant cell types. For another signal associated with blood glucose levels, we biochemically test all candidate causal variants from statistical fine-mapping using a pancreatic islet beta cell line and show biochemical evidence of allelic effects on TF binding for the model-prioritized variant. To aid in future research, we publicly distribute our model and islet enhancer perturbation scores across ~67 million genetic variants. We anticipate that DL methods like the one presented in this study will enhance the prioritization of candidate causal variants for functional studies.Keywords
All Related Versions
Funding Information
- HHS | National Institutes of Health (1-ZIA-HG000024)
- HHS | National Institutes of Health (R01DK118011)
- U.S. Department of War (W81XWH-18-0401)
- HHS | National Institutes of Health (1-ZIA-LM200881-12)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U01DK127777)
This publication has 46 references indexed in Scilit:
- TCF7L2 is a master regulator of insulin production and processingHuman Molecular Genetics, 2014
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and futureThe Lancet, 2014
- Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variantsProceedings of the National Academy of Sciences, 2013
- Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assayGenome Research, 2013
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Foxa1 and Foxa2 Maintain the Metabolic and Secretory Features of the Mature β-CellMolecular Endocrinology, 2010
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskNature Genetics, 2010
- CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinasesExpert Reviews in Molecular Medicine, 2009
- The emerging role of FOXO transcription factors in pancreatic β cellsJournal of Endocrinology, 2007
- Hepatocyte Nuclear Factor-4α Is Essential for Glucose-stimulated Insulin Secretion by Pancreatic β-CellsJournal of Biological Chemistry, 2006